Who owns AVALO THERAPEUTICS ORD?
- Ticker: AVTX
- CUSIP Number: 05338f306
Tip: Access positions for across all investors
Analyze quarterly positions in Avalo Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avalo Therapeutics Ord stock
Who bought or sold AVALO THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 1.4M | $17M | 32% | Sep 2025 |
|
| OrbiMed Advisors | 1.3M | $17M | 40% | Sep 2025 |
|
| Nantahala Capital Management | 1.2M | $16M | 24% | Sep 2025 |
|
| Point72 Asset Management | 1.1M | $13M | 100% | Sep 2025 |
|
| Affinity Asset Advisors | 1.0M | $13M | 66% | Sep 2025 |
|
| Caligan Partners | 833k | $11M | 100% | Sep 2025 |
|
| Balyasny Asset Management | 817k | $10M | 100% | Sep 2025 |
|
| Vanguard Group | 804k | $15M | 16% | Dec 2025 |
|
| Silverarc Capital Management | 721k | $9.2M | 100% | Sep 2025 |
|
| RA Capital Management | 663k | $8.4M | -29% | Sep 2025 |
|
| Marshall Wace | 508k | $9.2M | 806% | Dec 2025 |
|
| Citadel Advisors | 493k | $6.3M | 100% | Sep 2025 |
|
| TCG Crossover Management | 483k | $6.1M | 0% | Sep 2025 |
|
| Commodore Capital | 483k | $6.1M | 0% | Sep 2025 |
|
| UBS Group | 478k | $8.6M | 957% | Dec 2025 |
|
| Jennison Associates | 476k | $8.6M | 100% | Dec 2025 |
|
| Velan Capital Investment Management | 264k | $3.4M | 70% | Sep 2025 |
|
| Adage Capital Partners GP | 259k | $3.3M | 100% | Sep 2025 |
|
| Boothbay Fund Management | 228k | $2.9M | 1917% | Sep 2025 |
|
| Ameriprise Financial | 214k | $2.7M | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 198k | $3.6M | 3954840% | Dec 2025 |
|
| Nan Fung Trinity | 189k | $3.4M | 100% | Dec 2025 |
|
| Superstring Capital Management | 188k | $2.4M | 100% | Sep 2025 |
|
| Ally Bridge Group | 178k | $2.3M | 100% | Sep 2025 |
|
| Geode Capital Management | 166k | $3.0M | 59% | Dec 2025 |
|
| Ikarian Capital | 160k | $2.0M | 353% | Sep 2025 |
|
| BlackRock | 154k | $2.0M | -1% | Sep 2025 |
|
| DLD Asset Management | 152k | $1.9M | 100% | Sep 2025 |
|
| Deep Track Capital | 145k | $1.8M | -75% | Sep 2025 |
|
| Perceptive Advisors | 140k | $1.8M | 0% | Sep 2025 |
|
| Millennium Management | 137k | $1.7M | 100% | Sep 2025 |
|
| Moody Aldrich Partners | 133k | $2.4M | 100% | Dec 2025 |
|
| Boxer Capital Management | 125k | $1.6M | 100% | Sep 2025 |
|
| Susquehanna International | 112k | $1.4M | 100% | Sep 2025 |
|
| Barclays | 106k | $1.9M | 1032% | Dec 2025 |
|
| Exome Asset Management | 100k | $1.3M | 100% | Sep 2025 |
|
| Patient Square Capital | 100k | $1.3M | 100% | Sep 2025 |
|
| Standard Life Aberdeen | 95k | $1.7M | 31% | Dec 2025 |
|
| Adviser Investments | 87k | $1.1M | -67% | Sep 2025 |
|
| Cantor Fitzgerald, L. P. | 85k | $1.1M | 100% | Sep 2025 |
|
| State Street Corporation | 79k | $1.4M | 74% | Dec 2025 |
|
| Sio Capital Management | 72k | $917k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 65k | $1.2M | 100% | Dec 2025 |
|
| Two Sigma Investments | 49k | $626k | 282% | Sep 2025 |
|
| Walleye Trading Advisors | 42k | $757k | -7% | Dec 2025 |
|
| Landscape Capital Management | 33k | $424k | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 32k | $412k | -69% | Sep 2025 |
|
| Birchview Capital | 31k | $394k | 100% | Sep 2025 |
|
| HighVista Strategies | 28k | $353k | 100% | Sep 2025 |
|
| Springbok Capital Management | 25k | $313k | 100% | Sep 2025 |
|
| OMERS Administration Corporation | 20k | $356k | 100% | Dec 2025 |
|
| Northern Trust | 19k | $236k | -18% | Sep 2025 |
|
| Renaissance Technologies | 18k | $332k | -81% | Dec 2025 |
|
| Hudson Bay Capital Management | 17k | $305k | 100% | Dec 2025 |
|
| XTX Topco | 14k | $177k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 11k | $143k | 100% | Sep 2025 |
|
| Us Bancorp | 2.7k | $50k | 100% | Dec 2025 |
|
| PFS Partners | 2.0k | $36k | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.6k | $20k | 100% | Sep 2025 |
|
| Acadian Asset Management | 1.5k | $26k | 100% | Dec 2025 |
|
| Simplex Trading | 748.00 | $9.0k | 100% | Sep 2025 |
|
| Group One Trading | 281.00 | $3.6k | 28000% | Sep 2025 |
|
| Tower Research Capital | 26.00 | $329.999800 | 100% | Sep 2025 |
|
| SBI Securities | 23.00 | $292.001100 | 5% | Sep 2025 |
|
| Advisor Group Holdings | 2.00 | $18.000000 | 0% | Sep 2025 |
|
| Activest Wealth Management | 1.00 | $18.000000 | 0% | Dec 2025 |
|
| Key FInancial | 1.00 | $18.000000 | 0% | Dec 2025 |
|
| Parallel Advisors | 1.00 | $13.000000 | 0% | Sep 2025 |
|
Who sold out of Avalo Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Efficient Wealth Management | Sep 2025 | 5.00 | $0 |
| Raymond James Financial | Jun 2025 | 1.00 | $5.000000 |